News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Author: mark

Epigenomics AG: Executive Board and Supervisory Board recommend acceptance of the voluntary public takeover offer

DGAP-News: Epigenomics AG / Key word(s): Offer 14.06.2017 / 08:55 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG: Executive Board and Supervisory Board recommend acceptance of the voluntary public takeover offer Berlin, 14 June 2017 – The Executive Board and Supervisory Board of Epigenomics AG (Frankfurt Prime Standard: […]

Read more

Epigenomics AG: Offer document published for the voluntary public takeover offer for Epigenomics AG

DGAP-News: Epigenomics AG / Key word(s): Offer 08.06.2017 / 10:55 The issuer is solely responsible for the content of this announcement. Press release Offer document published for the voluntary public takeover offer for Epigenomics AG Berlin, 8 June 2017 – Today Summit Hero Holding GmbH published the offer document for the voluntary takeover offer for […]

Read more

Epigenomics AG announces 2017 First Quarter Financial Results

DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement 10.05.2017 / 08:00 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG announces 2017 First Quarter Financial Results Berlin (Germany) and Germantown, MD (U.S.A.), May 10, 2017 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY), or the “Company”, today announced […]

Read more

Epigenomics AG Reports Results for Financial Year 2016

DGAP-News: Epigenomics AG / Key word(s): Final Results/Forecast 26.04.2017 / 04:39 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG Reports Results for Financial Year 2016 Berlin (Germany) and Germantown, MD (U.S.A.), April 26, 2017 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY), or the “Company”, today announced its financial […]

Read more

Epigenomics AG: Blitz F16-83 GmbH to launch takeover offer for Epigenomics AG

DGAP-News: Epigenomics AG / Key word(s): Takeover 26.04.2017 / 04:02 The issuer is solely responsible for the content of this announcement. Press release Blitz F16-83 GmbH to launch takeover offer for Epigenomics AG – Shareholders will be offered 7.52 Euros in cash per share valuing Epigenomics at approximately 171 million Euros – The offer reflects […]

Read more

Epigenomics AG: U.S. Department of Veterans Affairs awards supply contract for Epi proColon(R)

DGAP-News: Epigenomics AG / Key word(s): Contract 03.03.2017 / 11:40 The issuer is solely responsible for the content of this announcement. Press ReleaseEpigenomics AG: U.S. Department of Veterans Affairs awards supply contract for Epi proColon(R)Berlin (Germany) and Germantown, MD (U.S.A.), March 3, 2017 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), today announced that […]

Read more